Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 2/20 | 0.39 |
| ▸ | CHRNA10 | Q9GZZ6 | 2/20 | 0.39 |
| ▸ | CHRNA9 | Q9UGM1 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15242149 | 0.88 | CHRNA7 (0.33) | CHRNA7CHRNA10CHRNA9 | |
| SCHEMBL2179678 | 0.87 | HTR2C (0.38) | CHRNA7CHRNA10CHRNA9 | |
| SCHEMBL1315019 | 0.81 | APP (0.50) | — | |
| SCHEMBL14465889 | 0.80 | — | — | |
| SCHEMBL2800429 | 0.80 | CHRNB2 (0.39) | CHRNA7CHRNA10CHRNA9 | |
| SCHEMBL2180140 | 0.79 | CYP1A2 (0.50) | CHRNA7CHRNA10CHRNA9 | |
| SCHEMBL1875968 | 0.75 | GABRP (0.41) | CHRNA7CHRNA10CHRNA9 | |
| SCHEMBL3348718 | 0.73 | CYP1A2 (0.47) | CHRNA7CHRNA10CHRNA9 | |
| SCHEMBL18112925 | 0.72 | APP (0.47) | — | |
| SCHEMBL2799266 | 0.72 | KDM4E (0.43) | CHRNA7CHRNA10CHRNA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8940774-B2 | Tris-Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors | UNIV KENTUCKY RES FOUND (US) | 2015-01-27 | — | — | US | disclosed |
| US-8940774-B2 | Tris-Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors | UNIV KENTUCKY RES FOUND (US) | 2015-01-27 | — | — | US | disclosed |
| US-8940774-B2 | Tris-Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors | UNIV KENTUCKY RES FOUND (US) | 2015-01-27 | — | — | US | disclosed |
| US-8703803-B2 | Tris-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors | UNIV KENTUCKY RES FOUND (US) | 2014-04-22 | — | — | US | disclosed |
| US-8703803-B2 | Tris-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors | UNIV KENTUCKY RES FOUND (US) | 2014-04-22 | — | — | US | disclosed |
| US-8703803-B2 | Tris-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors | UNIV KENTUCKY RES FOUND (US) | 2014-04-22 | — | — | US | disclosed |
| US-20140080866-A1 | Tris-Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2014-03-20 | — | — | US | disclosed |
| US-20140080866-A1 | Tris-Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2014-03-20 | — | — | US | disclosed |
| US-20140080866-A1 | Tris-Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2014-03-20 | — | — | US | disclosed |
| US-20130231366-A1 | Use of a Novel Alpha-7 Nachr Antagonist to Suppress Pathogenic Signal Transduction in Cancer and Aids | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2013-09-05 | — | — | US | disclosed |
| US-20130030018-A1 | Tris-Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors | UNIV KENTUCKY RES FOUND (US) | 2013-01-31 | — | — | US | disclosed |
| US-8299253-B2 | Tris-quarternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2012-10-30 | — | — | US | disclosed |
| US-8299253-B2 | Tris-quarternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2012-10-30 | — | — | US | disclosed |
| US-8299253-B2 | Tris-quarternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2012-10-30 | — | — | US | disclosed |
| US-20110105556-A1 | TRIS-QUARTERNARY AMMONIUM SALTS AND METHODS FOR MODULATING NEURONAL NICOTINIC ACETYLCHOLINE RECEPTORS | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2011-05-05 | — | — | US | disclosed |
| US-20110105556-A1 | TRIS-QUARTERNARY AMMONIUM SALTS AND METHODS FOR MODULATING NEURONAL NICOTINIC ACETYLCHOLINE RECEPTORS | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2011-05-05 | — | — | US | disclosed |
| US-20110105556-A1 | TRIS-QUARTERNARY AMMONIUM SALTS AND METHODS FOR MODULATING NEURONAL NICOTINIC ACETYLCHOLINE RECEPTORS | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2011-05-05 | — | — | US | disclosed |
| US-20100179186-A1 | USE OF A NOVEL ALPHA-7 nAChR ANTAGONIST TO SUPPRESS PATHOGENIC SIGNAL TRANSDUCTION IN CANCER AND AIDS | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2010-07-15 | — | — | US | disclosed |
| US-20100179186-A1 | USE OF A NOVEL ALPHA-7 nAChR ANTAGONIST TO SUPPRESS PATHOGENIC SIGNAL TRANSDUCTION IN CANCER AND AIDS | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) | 2010-07-15 | — | — | US | disclosed |
| WO-2007076112-A2 | TRIS-QUATERNARY AMMONIUM SALTS AND METHODS FOR MODULATING NEURONAL NICOTINIC ACETYLCHOLINE RECEPTORS | UNIVERSITY OF KENTUCKY (US) | 2007-07-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130030018-A1 | Tris-Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors | CHRNA10, CHRNA5, CHRNA2 | CHRNA7 6/4885CHRNA10 1/4885CHRNA9 9/4885 |
| US-20100179186-A1 | USE OF A NOVEL ALPHA-7 nAChR ANTAGONIST TO SUPPRESS PATHOGENIC SIGNAL TRANSDUCTION IN CANCER AND AIDS | CHRNA7, CHRNG, CHRNE | CHRNA7 1/4885CHRNA10 8/4885CHRNA9 13/4885 |
| US-20130231366-A1 | Use of a Novel Alpha-7 Nachr Antagonist to Suppress Pathogenic Signal Transduction in Cancer and Aids | CHRNA7, CHRNG, CHRNE | CHRNA7 1/4885CHRNA10 8/4885CHRNA9 13/4885 |
| US-20140080866-A1 | Tris-Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors | CHRNA4, CHRNA2, CHRNA10 | CHRNA7 7/4885CHRNA10 3/4885CHRNA9 11/4885 |
| US-20110105556-A1 | TRIS-QUARTERNARY AMMONIUM SALTS AND METHODS FOR MODULATING NEURONAL NICOTINIC ACETYLCHOLINE RECEPTORS | CHRNA5, CHRNA10, CHRNA4 | CHRNA7 4/4885CHRNA10 2/4885CHRNA9 9/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.